Home Capital Broker's Calls

Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug

Amala Balakrishner
Amala Balakrishner7/27/2021 01:13 PM GMT+08  • 4 min read
Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug
The group’s PATMI of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Photo of Raffles Hospital Shanghai: Raffles Medical Group

The latest 1H2021 earnings of Raffles Medical Group shows that the healthcare provider has been immunised to the coronavirus.

The group’s PATMI (profit after taxes minus interest) of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now